QualityStocksNewsBreaks Archives - Page 335 of 1544

ThursdayNov 02, 2023 10:37 am

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present Phase 2 Study Results for INM-755 at 12th Annual WCI

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, will be presenting an oral presentation at the 12th World Congress on Itch (“WCI”); the event is scheduled for Nov. 5–7, 2023, in Miami. According to the announcement, the oral presentation is based on an abstract describing the phase 2 clinical study of investigational drug INM-755 cannabinol cream for the treatment of symptoms in patients with rare genetic skin disease called epidermolysis bullosa ("EB"). InMed Pharmaceuticals senior vice president of Clinical and Regulatory Affairs Alexandra Mancini will be presenting. The…

WednesdayNov 01, 2023 2:19 pm

QualityStocksNewsBreaks — SenesTech Inc. (NASDAQ: SNES) Now Taking Orders for Evolve(TM) Soft Bait

SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, announced that it is now taking orders from commercial customers for Evolve(TM) Soft Bait (“Evolve(TM)”), a solution designed to reduce fertility in rats, for shipment on or before Nov. 13. According to the announcement, the company already has received advanced purchase commitments from key customers. “Evolve was developed to offer customers a soft bait product that has similar efficacy to ContraPest(R), but in a format that is easier to deploy and that they can use daily in their integrated pest management programs,” said Joel Fruendt, SenesTech’s president…

WednesdayNov 01, 2023 2:12 pm

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) to Present at BIO-Europe 2023

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes, today announced that Catherine Vaczy, its EVP, general counsel and chief strategy officer, will be providing an overview of the company’s gene therapies for cancer and diabetes at the upcoming BIO-Europe 2023 Conference taking place in Munich, Germany. Vaczy’s presentation is slated to begin at 4:45 p.m UTC on Tuesday, Nov. 7, 2023. Several members of Genprex’s executive leadership team will be in attendance at BIO-Europe 2023. Those interested in meeting Genprex management during the event should request a meeting through…

WednesdayNov 01, 2023 2:05 pm

QualityStocksNewsBreaks – RJD Green Inc. (RJDG) Reports on Annual Financial Results, Files Annual Report in Timely Manner

RJD Green (OTC: RJDG), a publicly traded company that operates as a holding company focusing on acquiring and managing assets, and actively exploring potential acquisitions and opportunities in diversified industries, has filed its annual report for the year ended Aug. 31, 2023. Notable results from the financial report include revenue totaling $5,019,239 and a net profit of $642,678, with cash and cash equivalents of $819,724 as of Aug. 31, 2023. The report also noted that the company has monthly recurring revenues of $418,269 with $2,455,631 in assets, liabilities of $334,039 as of the same date. The report noted that 2023…

WednesdayNov 01, 2023 1:18 pm

QualityStocksNewsBreaks – Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0) Announces Entry into Multinational Distribution Agreement in the Middle East

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0), a leading Swiss hosted secure and private communications platform, today announced that it has signed a major distribution agreement with a distributor in the Hashemite Kingdom of Jordan and the Republic of Iraq in order to distribute its entire Sekur Swiss-hosted private and encrypted communications platform. According to the announcement, Sekur’s distribution agreement was signed with Solutions Communications & Security Systems (“SOLCOM”), a Jordanian corporation from Amman, Jordan, and is valid for a period of 12 months, with renewal options for additional 12 months. “We are thrilled to have signed this…

WednesdayNov 01, 2023 12:55 pm

QualityStocksNewsBreaks – Prospera Energy Inc. (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B) Reports on Q3 2023 Performance, Debt Financing

Prospera Energy (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B), a public oil and gas exploration, exploitation and development company focusing on conventional oil and gas reservoirs in western Canada, is reporting on its third-quarter production and financial results. According to the announcement, the company is steadily recovering production rates that had been impacted by adverse weather in earlier quarters, with PEI reaching gross peak rates of 770+ boe/d, with another 350 boe/d behind the pipe to be optimized. In addition, the report noted that phase 2 development drilling had begun during the quarter, which necessitated the temporary shut-in of the adjacent…

WednesdayNov 01, 2023 12:29 pm

QualityStocksNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Reports on Progress at Bolivian Iska Iska Project

Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mine-development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec, has completed a metallurgical drill program at its Iska Iska silver-tin polymetallic project in the Potosi Department of southwestern Bolivia. The company is now conducting a definition drill program designed to fill-in major gaps in the block model as well as expand the higher-grade zone both along and across strike. According to the announcement, work will also be completed on improving tin recovery for future use, which is a major, very underexplored, exploration target…

TuesdayOct 31, 2023 2:08 pm

QualityStocksNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Releases Q3 2023 Financial Report, Reports Possible Adjustment of Facility Terms by EIB

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative inflammation and immunology (“I&I”) biological products primarily for the treatment of autoimmune and infectious diseases, is reporting on its financial results for the third quarter ended Sept. 30, 2023; the report also included key business updates. Financial numbers to note in the report include R&D expenses of $1.13 million compared to $1.19 million for the same quarter in 2022; marketing, general and administrative expenses for the quarter totaled $0.97 million compared to $0.96 million for the three months ended Sept. 30, 2022; total operating expenses for the quarter came in at…

TuesdayOct 31, 2023 2:00 pm

QualityStocksNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Host Third Quarter 2023 Results Conference Call

HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only credit card-size 3D-vector electrocardiogram (“VECG”) platform for patient use at home, announced that it will hold a conference call on Tuesday, Nov. 14, 2023, at 4:30 p.m. Eastern Time to discuss its results for the third quarter ended Sept. 30, 2023. The company will also review recent announcements, ongoing initiatives and anticipated 2024 milestones. HeartBeam CEO and Founder Branislav Vajdic, PhD, President Robert Eno and CFO Richard Brounstein will host the call, followed by a question-and-answer period. Accompanying the conference call will be a presentation, which…

TuesdayOct 31, 2023 1:51 pm

QualityStocksNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Reports on Voting at Annual Meeting

Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mine-development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec, is reporting on the voting held during its annual shareholder meeting. The meeting was held virtually on Oct. 30, 2023. According to the report, a total of 29,893,834 common shares representing 38.90% of the company`s issued and outstanding common shares were voted in connection with the meeting. The shareholders attending the meeting voted in favor of the six director nominees, including Thomas Larsen, Francis Sauve, Alexander Horvath, Dusan Berka, Richard Stone and Pablo Ordoñez;…

Site Search

Company Search

Category: QualityStocksNewsBreaks